This underscores how strongly these cells depend on proteasome integrity, making it even more plausible that many
cancer cell types are particularly susceptible to proteasome inhibition55. In addition, based on a synthetic lethality screen, the use of proteasome inhibitors was suggested as a strategy for eliminating cells with oncogenic RAS56.